Sign Up Today and Learn More About Naveris Stock
Invest in or calculate the value of your shares in Naveris or other pre-IPO companies through EquityZen's platform.
Naveris Stock (NAVE)
Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.
About Naveris Stock
Founded
2017
Headquarters
Waltham, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Naveris Press Mentions
Stay in the know about the latest news on Naveris
New Multicenter Study Highlights Use of the NavDx® Test in Resolving Clinically Indeterminate Findings
businesswire • Aug 04, 2024
Naveris to Present New Data Highlighting Clinical Utility of the NavDx® Test at the 2024 ASCO Annual Meeting
finance • Jun 25, 2024
CMS Designates the NavDx® Test as an Advanced Diagnostic Laboratory Test (ADLT)
businesswire • May 19, 2024
Naveris Announces Launch of Phase II Clinical Study in MRD+ Head and Neck Cancer
businesswire • May 19, 2024
Naveris Unveils NAVigate-HPV: A Groundbreaking Registry to Advance HPV-Driven Cancer Diagnosis and Treatment
businesswire • May 05, 2024
Naveris Management
Leadership team at Naveris
Chief Scientific Officer
Phil Stephens
Co-Founder, CEO & Chairman
Piyush Gupta
Join now and verify your accreditation status to gain access to:
- Naveris current valuation
- Naveris stock price
- Available deals in Naveris and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Naveris stock?
Accredited investors can buy pre-IPO stock in companies like Naveris through EquityZen funds. These investments are made available by existing Naveris shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Naveris stock?
Shareholders can sell their Naveris stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
